Abstract
Free energy perturbation theory, in combination with enhanced sampling of protein-ligand binding modes, is evaluated in the context of fragment-based drug design, and used to design two new small-molecule inhibitors of the Aurora A kinase-TPX2 protein-protein interaction.
MeSH terms
-
Aurora Kinase A / antagonists & inhibitors*
-
Aurora Kinase A / chemistry
-
Aurora Kinase A / metabolism
-
Cell Cycle Proteins / antagonists & inhibitors*
-
Cell Cycle Proteins / chemistry
-
Cell Cycle Proteins / metabolism
-
Humans
-
Microtubule-Associated Proteins / antagonists & inhibitors*
-
Microtubule-Associated Proteins / chemistry
-
Microtubule-Associated Proteins / metabolism
-
Models, Molecular
-
Molecular Dynamics Simulation*
-
Molecular Structure
-
Nuclear Proteins / antagonists & inhibitors*
-
Nuclear Proteins / chemistry
-
Nuclear Proteins / metabolism
-
Protein Binding / drug effects
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / pharmacology*
-
Small Molecule Libraries / chemistry
-
Small Molecule Libraries / pharmacology*
Substances
-
Cell Cycle Proteins
-
Microtubule-Associated Proteins
-
Nuclear Proteins
-
Protein Kinase Inhibitors
-
Small Molecule Libraries
-
TPX2 protein, human
-
Aurora Kinase A